Applied Health Economics and Health Policy

Papers
(The H4-Index of Applied Health Economics and Health Policy is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide91
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework89
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas41
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version33
Comment on: “Willingness to Pay for a COVID-19 Vaccine”32
Values in Modelling: Video Series Development and Evaluation Survey32
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults28
Effect of Competition on Generic Drug Prices28
Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis27
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana25
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies22
Are Drug Novelty Characteristics Associated With Greater Health Benefits?21
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–204021
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi20
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment20
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries19
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review19
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models17
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis17
0.07335090637207